<DOC>
	<DOCNO>NCT00060996</DOCNO>
	<brief_summary>The purpose study ass compare safety continuous daily subcutaneous Remodulin therapy patient critical limb ischemia ( CLI ) plan vascular interventional procedure ; determine effect Remodulin wound heal treadmill walk distance .</brief_summary>
	<brief_title>Study Remodulin Patients With Critical Limb Ischemia With No Planned Revascularization Procedures</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Treprostinil</mesh_term>
	<criteria>Patients Stage III IV critical limb ischemia due document peripheral arterial disease plan interventional vascular procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Critical Limb Ischemia</keyword>
	<keyword>Peripheral Vascular Disease</keyword>
	<keyword>UT-15</keyword>
	<keyword>Remodulin</keyword>
	<keyword>treprostinil</keyword>
</DOC>